Noninvasive Prenatal Diagnosis of Congenital Adrenal Hyperplasia Using Cell-Free Fetal DNA in Maternal Plasma
Open accessThe DOI matches its Crossref record; 27 of the 28 references it cites were found in a registry or an index.
Abstract
CONTEXT: Congenital adrenal hyperplasia (CAH) is an autosomal recessive condition that arises from mutations in CYP21A2 gene, which encodes for the steroidogenic enzyme 21-hydroxylase. To prevent genital ambiguity in affected female fetuses, prenatal treatment with dexamethasone must begin on or before gestational week 9. Currently used chorionic villus sampling and amniocentesis provide genetic results at approximately 14 weeks of gestation at the earliest. This means that mothers who want to undergo prenatal dexamethasone treatment will be unnecessarily treating seven of eight fetuses (males and three of four unaffected females), emphasizing the desirability of earlier genetic diagnosis in utero. OBJECTIVE: The objective of the study was to develop a noninvasive method for early prenatal diagnosis of fetuses at risk for CAH. PATIENTS: Fourteen families, each with a proband affected by phenotypically classical CAH, were recruited. DESIGN: Cell-free fetal DNA was obtained from 3.6 mL of maternal plasma. Using hybridization probes designed to capture a 6-Mb region flanking CYP21A2, targeted massively parallel sequencing (MPS) was performed to analyze genomic DNA samples from parents and proband to determine parental haplotypes. Plasma DNA from pregnant mothers also underwent targeted MPS to deduce fetal inheritance of parental haplotypes. RESULTS: In all 14 families, the fetal CAH status was correctly deduced by targeted MPS of DNA in maternal plasma, as early as 5 weeks 6 days of gestation. CONCLUSIONS: MPS on 3.6 mL plasma from pregnant mothers could potentially provide the diagnosis of CAH, noninvasively, before the ninth week of gestation. Only affected female fetuses will thus be treated. Our strategy represents a generic approach for noninvasive prenatal testing for an array of autosomal recessive disorders.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Noninvasive cell-free fetal DNA testing enables fetal sex determination and genotyping as early as 4–5 weeks of gestation, allowing prenatal therapy to be limited to affected females only (16, 100).”
From Evolution of molecular diagnostic strategies for 21-hydroxylase deficiency: from classical methods to advanced genomic techniques (2026) · cites this paper as [100]
In the citing paper
“Prenatal sex typing (SRY detection) can be performed using PCR amplification of cell-free fetal DNA as early as week 6-9 (323)”
From Congenital Adrenal Hyperplasia—Current Insights in Pathophysiology, Diagnostics, and Management (2022) · cites this paper as [323]
In the citing paper
“By using blood from both parents and an affected proband and applying massively parallel DNA sequencing coupled with extensive analysis of single nucleotide polymorphisms near the CYP21A2 gene, it was possible to determine the CYP21A2 genotype in 14 of 14 at-risk fetuses within 3 weeks of obtaining fetal DNA in maternal blood samples (99).”
From Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society* Clinical Practice Guideline (2018) · cites this paper as [99]
Citations
Cites
Speiser, P. W., Azziz, R., Baskin, L. S., Ghizzoni, L., Hensle, T. W., Merke, D. P., Meyer-Bahlburg, H. F. L., Miller, W. L., Montori, V. M., Oberfield, S. E., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2631 · Cited by 1,468 · cited 5×
“E1028 New et al Noninvasive CAH Diagnosis Using Maternal Plasma DNA J Clin Endocrinol Metab, June 2014, 99(6):E1022–E1030”
MethodInfluentialMaternal Plasma DNA Sequencing Reveals the Genome-Wide Genetic and Mutational Profile of the Fetus
Lo, Y. M. D., Chan, K. C. A., Sun, H., Chen, E. Z., Jiang, P., Lun, F. M. F., Zheng, Y. W., Leung, T. Y., Lau, T. K., Cantor, C. R., et al. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3001720 · Cited by 1,101 · cited 12×
“Notably, to determine inheritance, we carried out relative haplotype dosage analysis (RHDO) (7, 8) to establish overrepresentation of the maternal and paternal haplotypes in the pregnant mother’s plasma with reference to the respective noninherited haplotypes.”
MethodSelf-citationProcedure-Related Complications of Amniocentesis and Chorionic Villous Sampling: A Systematic Review
Mujezinovic, F., & Alfirevic, Z. (2007) · Obstetrics & Gynecology · doi:10.1097/01.aog.0000278820.54029.e3 · Cited by 446
Digital PCR for the molecular detection of fetal chromosomal aneuploidy
Lo, Y. M. D., Lun, F. M. F., Chan, K. C. A., Tsui, N. B. Y., Chong, K. C., Lau, T. K., Leung, T. Y., Zee, B. C. Y., Cantor, C. R., & Chiu, R. W. K. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0705765104 · Cited by 434 · cited 11×
“We thus proceeded to investigate in silico the effects of varying fractional fetal DNA concentrations on the SPRT analysis (see Supplemental Methods and Supplemental Table 3).”
MethodSelf-citationPang, S., Wallace, M. A., Hofman, L., Thuline, H. C., Dorche, C., Lyon, I. C. T., Dobbins, R. H., Kling, S., Fujieda, K., & Suwa, S. (1988) · Journal of Urology · doi:10.1016/s0022-5347(17)42164-1 · Cited by 392 · cited 1×
“Affecting 1 of 15 000 live births worldwide (1, 2), the disease is characterized by varying levels of impairments in mineralocorticoid and glucocorticoid synthesis, over-”
BackgroundNew, M. I., Abraham, M., Gonzalez, B., Dumic, M., Razzaghy-Azar, M., Chitayat, D., Sun, L., Zaidi, M., Wilson, R. C., & Yuen, T. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1300057110 · Cited by 365 · cited 5×
“Remarkably, both children had the same mutation, del/ V281L, but had variable phenotypes (2, 4).”
BackgroundSelf-citationWhere the crossovers are: recombination distributions in mammals
Kauppi, L., Jeffreys, A. J., & Keeney, S. (2004) · Nature Reviews Genetics · doi:10.1038/nrg1346 · Cited by 307 · cited 1×
“These results could most likely be explained by a recombination event in a major histocompatibility complex class II recombination hot spot (12, 13), which we confirmed with targeted MPS on the newborn’s DNA.”
BackgroundTsui, N. B. Y., Kadir, R. A., Chan, K. C. A., Chi, C., Mellars, G., Tuddenham, E. G., Leung, T. Y., Lau, T. K., Chiu, R. W. K., & Lo, Y. M. D. (2011) · Blood · doi:10.1182/blood-2010-10-310789 · Cited by 260 · cited 1×
“(21), cystic fibrosis (22), and Gaucher disease (23).”
BackgroundSelf-citationPang, S., Wallace, M. A., Hofman, L. F., Thuline, H. C., Dorche, C., Lyon, I. C. T., Dobbins, R. H., Kling, S., Fujieda, K., & Suwa, S. (1988) · PEDIATRICS · doi:10.1542/peds.81.6.866 · Cited by 191
Lam, K.-W. G., Jiang, P., Liao, G. J. W., Chan, K. C. A., Leung, T. Y., Chiu, R. W. K., & Lo, Y. M. D. (2012) · Clinical Chemistry · doi:10.1373/clinchem.2012.189589 · Cited by 189 · cited 13×
“ssemia (8), 11 -hydroxylase deficiency (20), hemophilia”
MethodSelf-citation
Cited by
Speiser, P. W., Arlt, W., Auchus, R. J., Baskin, L. S., Conway, G. S., Merke, D. P., Meyer-Bahlburg, H. F. L., Miller, W. L., Murad, M. H., Oberfield, S. E., et al. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-01865 · Cited by 1,234
Sun, K., Jiang, P., Chan, K. C. A., Wong, J., Cheng, Y. K. Y., Liang, R. H. S., Chan, W.-K., Ma, E. S. K., Chan, S. L., Cheng, S. H., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1508736112 · Cited by 774
Self-citationCongenital adrenal hyperplasia
El-Maouche, D., Arlt, W., & Merke, D. P. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31431-9 · Cited by 669
Congenital Adrenal Hyperplasia—Current Insights in Pathophysiology, Diagnostics, and Management
Claahsen - van der Grinten, H. L., Speiser, P. W., Ahmed, S. F., Arlt, W., Auchus, R. J., Falhammar, H., Flück, C. E., Guasti, L., Huebner, A., Kortmann, B. B. M., et al. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnab016 · Cited by 556
The Long and Short of Circulating Cell-Free DNA and the Ins and Outs of Molecular Diagnostics
Jiang, P., & Lo, Y. M. D. (2016) · Trends in Genetics · doi:10.1016/j.tig.2016.03.009 · Cited by 312
Self-citationMackie, F., Hemming, K., Allen, S., Morris, R., & Kilby, M. (2017) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.14050 · Cited by 292
Ahmed, S. F., Achermann, J. C., Arlt, W., Balen, A., Conway, G., Edwards, Z., Elford, S., Hughes, I. A., Izatt, L., Krone, N., et al. (2016) · Clinical Endocrinology · doi:10.1111/cen.12857 · Cited by 238
Chitty, L. S., Mason, S., Barrett, A. N., McKay, F., Lench, N., Daley, R., & Jenkins, L. A. (2015) · Prenatal Diagnosis · doi:10.1002/pd.4583 · Cited by 205
Chan, K. C. A., Jiang, P., Sun, K., Cheng, Y. K. Y., Tong, Y. K., Cheng, S. H., Wong, A. I. C., Hudecova, I., Leung, T. Y., Chiu, R. W. K., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1615800113 · Cited by 189
“First, it requires the elucidation of the maternal haplotype using a direct haplotyping approach (11–13), via pedigree analysis (8, 14), or via founder haplotype analysis in selected populations (15).”
MethodSelf-citationCongenital Adrenal Hyperplasia
Witchel, S. F. (2017) · Journal of Pediatric and Adolescent Gynecology · doi:10.1016/j.jpag.2017.04.001 · Cited by 184
Adrenal Steroidogenesis and Congenital Adrenal Hyperplasia
Turcu, A. F., & Auchus, R. J. (2015) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2015.02.002 · Cited by 177
Ståhlberg, A., Krzyzanowski, P. M., Egyud, M., Filges, S., Stein, L. D., & Godfrey, T. E. (2017) · Nature Protocols · doi:10.1038/nprot.2017.006 · Cited by 140
“4 | 2017 | 679 corrected data, and the optimal consensus depth for each SiMSenSeq assay will vary, Debarcer generates data sets for a range of consensus sequence depths (3, 10, 20, 30) by default.”
BackgroundStåhlberg, A., Krzyzanowski, P. M., Jackson, J., Egyud, M., Stein, L. D., & Godfrey, T. E. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw224 · Cited by 145
Prenatal Diagnosis Innovation: Genome Sequencing of Maternal Plasma
Wong, F. C. K., & Lo, Y. M. D. (2015) · Annual Review of Medicine · doi:10.1146/annurev-med-091014-115715 · Cited by 132
Self-citationUniversal Haplotype-Based Noninvasive Prenatal Testing for Single Gene Diseases
Hui, W. W. I., Jiang, P., Tong, Y. K., Lee, W., Cheng, Y. K. Y., New, M. I., Kadir, R. A., Chan, K. C. A., Leung, T. Y., Lo, Y. M. D., et al. (2016) · Clinical Chemistry · doi:10.1373/clinchem.2016.268375 · Cited by 128
Self-citationAhmed, S. F., Achermann, J. C., Alderson, J., Crouch, N. S., Elford, S., Hughes, I. A., Krone, N. P., McGowan, R., Mushtaq, T., O’Toole, S., et al. (2021) · Clinical Endocrinology · doi:10.1111/cen.14528 · Cited by 125
Baumgartner-Parzer, S., Witsch-Baumgartner, M., & Hoeppner, W. (2020) · European Journal of Human Genetics · doi:10.1038/s41431-020-0653-5 · Cited by 110
Sensitive Monogenic Noninvasive Prenatal Diagnosis by Targeted Haplotyping
Vermeulen, C., Geeven, G., de Wit, E., Verstegen, M. J. A. M., Jansen, R., van Kranenburg, M., de Bruijn, E., Pulit, S. L., Kruisselbrink, E., Shahsavari, Z., et al. (2017) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2017.07.012 · Cited by 115
“Furthermore, diagnosis should preferably be feasible without requiring the presence of a proband, 15,16,18,24,25 particularly in a society in which people increasingly have knowledge about their disease carrier status and therefore would want to apply NIPD to their first child.”
Disorders of sex development: effect of molecular diagnostics
Achermann, J. C., Domenice, S., Bachega, T. A. S. S., Nishi, M. Y., & Mendonca, B. B. (2015) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2015.69 · Cited by 116
The evolving role of genetic tests in reproductive medicine
Cariati, F., D’Argenio, V., & Tomaiuolo, R. (2019) · Journal of Translational Medicine · doi:10.1186/s12967-019-2019-8 · Cited by 116
Non-invasive prenatal diagnosis of spinal muscular atrophy by relative haplotype dosage
Parks, M., Court, S., Bowns, B., Cleary, S., Clokie, S. J. H., Hewitt, J., Williams, D., Cole, T. R. P., MacDonald, F., Griffiths, M., et al. (2017) · European Journal of Human Genetics · doi:10.1038/ejhg.2016.195 · Cited by 107
Hill, M. K., Twiss, P., Verhoef, T. I., Drury, S. C., McKay, F., Mason, S., Jenkins, L., Morris, S., & Chitty, L. S. (2015) · Prenatal Diagnosis · doi:10.1002/pd.4585 · Cited by 104
Jenkins, L., Deans, Z. C., Lewis, C., & Allen, S. K. (2017) · Prenatal Diagnosis · doi:10.1002/pd.5197 · Cited by 95
“This is particularly advantageous for genes with pseudogenes, larger gene deletions and pathogenic variants located within repetitive elements.(22) The RHDO approach determines the allelic ratios between two haplotypes in maternal plasma.”
BackgroundMethodParks, M., Court, S., Cleary, S., Clokie, S. J. H., Hewitt, J., Williams, D., Cole, T. R. P., MacDonald, F., Griffiths, M., & Allen, S. K. (2016) · Prenatal Diagnosis · doi:10.1002/pd.4781 · Cited by 91
“RHDO analysis for X-linked disorders Relative haplotype dosage analysismeasures the allelic imbalance between two haplotypes in plasma cfDNA to determine which haplotype has been inherited by the fetus.(19,20,24) Haplotype phasing is conducted through sequencing of SNPs.”
BackgroundMethodInfluentialHayward, J. D., & Chitty, L. S. (2018) · Seminars in Fetal and Neonatal Medicine · doi:10.1016/j.siny.2017.12.002 · Cited by 85
Chitty, L. S., & Lo, Y. M. D. (2015) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a023085 · Cited by 94
“To make this approach more cost-effective, Lam et al. (2012) and New et al. (2014) applied targeted versions of this approach to the genomic regions flanking the HBB gene and the CYP21A2 gene, for the NIPT of b-thalassemia and congenital adrenal hyperplasia (CAH) (Ma et al. 2014), respectively.”
BackgroundMethodSelf-citationNoninvasive Prenatal Diagnosis of Single-Gene Disorders by Use of Droplet Digital PCR
Camuñas-Soler, J., Lee, H.-J., Hudgins, L., Hintz, S. R., Blumenfeld, Y. J., El-Sayed, Y. Y., & Quake, S. R. (2017) · Clinical Chemistry · doi:10.1373/clinchem.2017.278101 · Cited by 87
Noninvasive Prenatal Diagnosis of Single-Gene Diseases: The Next Frontier
Scotchman, E., Chandler, N. J., Mellis, R., & Chitty, L. S. (2019) · Clinical Chemistry · doi:10.1373/clinchem.2019.304238 · Cited by 88
Shaw, J., Scotchman, E., Chandler, N. J., & Chitty, L. S. (2020) · Reproduction · doi:10.1530/rep-19-0591 · Cited by 87
Non-invasive prenatal diagnosis and screening for monogenic disorders
Scotchman, E., Shaw, J., Paternoster, B., Chandler, N. J., & Chitty, L. S. (2020) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2020.08.001 · Cited by 87
Non invasive prenatal testing (NIPT) for common aneuploidies and beyond
Alberry, M., Hamed, E. S., Ahmed, S. R., & Abdel‐Fattah, S. A. (2021) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2021.01.008 · Cited by 89
Yau, M., Haider, S. M., Khattab, A., Ling, C., Mathew, M., Zaidi, S., Bloch, M., Patel, M., Ewert, S., Abdullah, W., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1716621115 · Cited by 83
“To this end, using patients from our CAH cohort, we can now establish, as early as 6 wk of gestation, whether the fetus is affected or a carrier by nextgeneration sequencing of cell-free fetal DNA in the mother’s plasma (40).”
MethodSelf-citationBioinformatics Approaches for Fetal DNA Fraction Estimation in Noninvasive Prenatal Testing
Peng, X. L., & Jiang, P. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18020453 · Cited by 74
“Technologically, the development of relative haplotype dosage analysis (RHDO), which utilizes information regarding parental haplotypes flanking the variants of interest, has been demonstrated to greatly improve the accuracy of single-gene disorder detection [9,10,13].”
BackgroundSelf-citationDNA of Erythroid Origin Is Present in Human Plasma and Informs the Types of Anemia
Lam, W. K. J., Gai, W., Sun, K., Wong, R. S. M., Chan, R. W. Y., Jiang, P., Chan, N. P. H., Hui, W. W. I., Chan, A. W. H., Szeto, C.-C., et al. (2017) · Clinical Chemistry · doi:10.1373/clinchem.2017.272401 · Cited by 71
Self-citationThe next 150 years of congenital adrenal hyperplasia
Turcu, A. F., & Auchus, R. J. (2015) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2015.05.013 · Cited by 70
Verhoef, T. I., Hill, M. K., Drury, S., Mason, S., Jenkins, L., Stephen Morris, A., & Chitty, L. S. (2016) · Prenatal Diagnosis · doi:10.1002/pd.4832 · Cited by 68
“Using technologies such as digital PCR ormassively parallel sequencing, which allow accurate quantification of specific sequences, proof-of-concept studies have been performed using approaches such as relative mutation dosage for beta thalasaemia(13) and sickle cell disorder(14) or analysis of single-nucleotide polymo…”
MethodcfDNA screening and diagnosis of monogenic disorders – where are we heading?
Chiu, E. K. L., Hui, W. W. I., & Chiu, R. W. K. (2018) · Prenatal Diagnosis · doi:10.1002/pd.5207 · Cited by 71
“However, parental DNA haplotyping has not been a trivial task, and has generally been based on inference techniques either by statistical means using population haplotype information or based on familial structure through the analysis of a proband’s DNA.(4,6,10) However, proband DNA may not always be available, and oc…”
InfluentialSelf-citationHudecova, I., Jiang, P., Davies, J., Lo, Y. M. D., Kadir, R. A., & Chiu, R. W. K. (2017) · Blood · doi:10.1182/blood-2016-12-755017 · Cited by 63
“This approach is able to achieve a higher than 99% diagnostic sensitivity at a 200-fold sequencing depth for 500 analyzed SNPs in maternal plasma samples with fetal DNA fractions as low as 3%.(18) We particularly applied this approach for the noninvasive prenatal assessment of F8 int22h-related inversions because the…”
MethodResultSelf-citationBaronio, F., Ortolano, R., Menabò, S., Cassio, A., Baldazzi, L., Natale, V. D., Tonti, G., Vestrucci, B., & Balsamo, A. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20184605 · Cited by 60
“Diagnosis can be made in a few hours and as early as at 5 weeks of gestation [97].”
BackgroundGullo, G., Scaglione, M., Buzzaccarini, G., Laganà, A. S., Basile, G., Chiàntera, V., Cucinella, G., & Zaami, S. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm13010001 · Cited by 67
“New [39] 2014 14 Congenital adrenal hyperplasia CYP21A2 AR”
BackgroundHanson, B., Scotchman, E., Chitty, L. S., & Chandler, N. J. (2022) · Clinical Science · doi:10.1042/cs20210380 · Cited by 67
Yoo, S., Lim, B. C., Byeun, J., Hwang, H. Y., Kim, K. J., Hwang, Y. S., Lee, J. H., Park, J. S., Lee, Y.-S., Namkung, J., et al. (2015) · Clinical Chemistry · doi:10.1373/clinchem.2014.236380 · Cited by 60
Congenital Adrenal Hyperplasia: clinical symptoms and diagnostic methods
Podgórski, R., Aebisher, D., Stompor, M., Podgórska, D., & Mazur, A. (2018) · Acta Biochimica Polonica · doi:10.18388/abp.2017_2343 · Cited by 70
“…haplotype-based approach has an accuracy of 96.41% for the inferred maternal alleles and an accuracy of 97.81% for the inferred paternal alleles (New et al., 2014; Ma et al., 2014; Ma et al., 2017) Because the genotype can be correlated to the phenotype in CAH, genetic counseling helps to make…”
BackgroundInfluentialGenetics of congenital adrenal hyperplasia and genotype-phenotype correlation
Narasimhan, M. L., & Khattab, A. (2019) · Fertility and Sterility · doi:10.1016/j.fertnstert.2018.11.007 · Cited by 62
Self-citationDrag, M., & Kilpeläinen, T. O. (2020) · Physiological Genomics · doi:10.1152/physiolgenomics.00086.2020 · Cited by 59
Fetal Sex and RHD Genotyping with Digital PCR Demonstrates Greater Sensitivity than Real-time PCR
Sillence, K. A., Roberts, L. A., Hollands, H. J., Thompson, H. P., Kiernan, M., Madgett, T. E., Welch, C. R., & Avent, N. D. (2015) · Clinical Chemistry · doi:10.1373/clinchem.2015.239137 · Cited by 64
“4 Target 1 RHD7 Exon (7) FAM 75 Finning et al.”
BackgroundCell-Free Fetal DNA Testing for Prenatal Diagnosis
Drury, S. C., Hill, M. K., & Chitty, L. S. (2016) · Advances in clinical chemistry · doi:10.1016/bs.acc.2016.05.004 · Cited by 60
Bachelot, A., Grouthier, V., Courtillot, C., Dulon, J., & Touraine, P. (2017) · European Journal of Endocrinology · doi:10.1530/eje-16-0888 · Cited by 57
A guide to understanding the steroid pathway: New insights and diagnostic implications
Greaves, R. F., Jevalikar, G., Hewitt, J. K., & Zacharin, M. R. (2014) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2014.07.017 · Cited by 52
Non-invasive prenatal diagnosis of thalassemias using maternal plasma cell free DNA
Hudecova, I., & Chiu, R. W. K. (2016) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2016.10.016 · Cited by 53
Self-citationChandler, N. J., Ahlfors, H., Drury, S. C., Mellis, R., Hill, M. K., McKay, F., Collinson, C., Hayward, J. D., Jenkins, L., & Chitty, L. S. (2019) · Clinical Chemistry · doi:10.1373/clinchem.2019.305011 · Cited by 53
The Adrenal Cortex and its Disorders
Miller, W. L. (2009) · Brook's Clinical Pediatric Endocrinology · doi:10.1002/9781444316728.ch13 · Cited by 50
Hormone replacement in disorders of sex development: Current thinking
Hewitt, J. K., & Zacharin, M. (2015) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2015.03.002 · Cited by 50
Jang, S. S., Lim, B. C., Yoo, S., Shin, J.-Y., Kim, K. J., Seo, J., Kim, J., & Chae, J. (2018) · Scientific Reports · doi:10.1038/s41598-018-26941-0 · Cited by 52
Artificial intelligence and machine learning in cell-free-DNA-based diagnostics
Tsui, W., Ding, S. C., Jiang, P., & Lo, Y. M. D. (2025) · Genome Research · doi:10.1101/gr.278413.123 · Cited by 57
Self-citationNon-invasive fetal sex diagnosis in plasma of early weeks pregnants using droplet digital PCR
D’Aversa, E., Breveglieri, G., Pellegatti, P., Guerra, G., Gambari, R., & Borgatti, M. (2018) · Molecular Medicine · doi:10.1186/s10020-018-0016-7 · Cited by 53
“In particular, determination of fetal sex is especially useful in congenital adrenal hyperplasia, permitting the target therapy to female fetuses (New et al., 2014; Sillence et al., 2015).”
BackgroundDrury, S. C., Mason, S., McKay, F., Lo, K., Boustred, C. R., Jenkins, L., & Chitty, L. S. (2016) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-42044-8_14 · Cited by 55
Deactivated CRISPR Associated Protein 9 for Minor-Allele Enrichment in Cell-Free DNA
Aalipour, A., Dudley, J. C., Park, S.-M., Murty, S., Chabon, J. J., Boyle, E. A., Diehn, M., & Gambhir, S. S. (2018) · Clinical Chemistry · doi:10.1373/clinchem.2017.278911 · Cited by 50
Yang, X., Zhou, Q., Zhou, W., Zhong, M., Guo, X., Wang, X., Fan, X., Yan, S., Li, L., Lai, Y., et al. (2019) · Advanced Science · doi:10.1002/advs.201802332 · Cited by 53
Fetal endocrine therapy for congenital adrenal hyperplasia should not be done
Miller, W. L. (2015) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2015.01.005 · Cited by 40
Löwy, I. (2020) · Social Science & Medicine · doi:10.1016/j.socscimed.2020.113064 · Cited by 48
Wong, A. I. C., & Lo, Y. M. D. (2015) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2014.12.006 · Cited by 42
Self-citationJiang, P., Peng, X. L., Su, X., Sun, K., Yu, S. C. Y., Chu, W. I., Leung, T. Y., Sun, H., Chiu, R. W. K., Lo, Y. M. D., et al. (2016) · npj Genomic Medicine · doi:10.1038/npjgenmed.2016.13 · Cited by 40
“In particular, the fetal DNA fraction is a key parameter for determining whether the imbalance between wildtype and mutant molecules in maternal plasma is statistically significant in the diagnosis of monogenic diseases.(11,12,14) In such analyses, fetal DNA fraction is integrated in the mathematical models that are u…”
BackgroundSelf-citationSaba, L., Masala, M., Capponi, V., Marceddu, G., Massidda, M., & Rosatelli, M. C. (2017) · European Journal of Human Genetics · doi:10.1038/ejhg.2017.26 · Cited by 40
Chang, M. Y., Ahn, S., Kim, M. Y., Han, J. H., Park, H.-R., Seo, H. K., Yoon, J., Lee, S., Oh, D., Kang, C. P., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-21236-w · Cited by 38
Jiang, F., Liu, W., Zhang, L., Guo, Y., Chen, M., Zeng, X., Wang, Y., Li, Y., Xian, J., Du, B., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-85128-2 · Cited by 43
Ma, D., Yuan, Y., Luo, C., Wang, Y., Jiang, T., Guo, F., Zhang, J., Chen, C., Sun, Y., Cheng, J., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-06828-2 · Cited by 37
Prenatal genetic testing and treatment for congenital adrenal hyperplasia
Simpson, J. L., & Rechitsky, S. (2019) · Fertility and Sterility · doi:10.1016/j.fertnstert.2018.11.041 · Cited by 36
The classic and nonclassic concenital adrenal hyperplasias
Auchus, R. J. (2015) · Endocrine Practice · doi:10.4158/ep14474.ra · Cited by 35
Recent advances of genomic testing in perinatal medicine
Peters, D. G., Yatsenko, S. A., Surti, U., & Rajkovic, A. (2014) · Seminars in Perinatology · doi:10.1053/j.semperi.2014.10.009 · Cited by 38
Noninvasive prenatal diagnosis by genome-wide haplotyping of cell-free plasma DNA
Che, H., Villela, D., Dimitriadou, E., Melotte, C., Brison, N., Neofytou, M. C., Bogaert, K. V. D., Tšuiko, O., Devriendt, K., Legius, E., et al. (2020) · Genetics in Medicine · doi:10.1038/s41436-019-0748-y · Cited by 41
Ye, J., Chen, C., Yuan, Y., Han, L., Wang, Y., Qiu, W., Zhang, H., Asan, & Gu, X. (2018) · Scientific Reports · doi:10.1038/s41598-017-18358-y · Cited by 33
Precision Medicine: Functional Advancements
Caskey, C. T. (2017) · Annual Review of Medicine · doi:10.1146/annurev-med-041316-090905 · Cited by 35
Molecular diagnosis of steroid 21-hydroxylase deficiency: A practical approach
Arriba, M., & Ezquieta, B. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.834549 · Cited by 30
“For its application, massive sequencing based on an indirect analyses conducted by SNP-haplotypes previously defined in parents and index case is necessary due to the coexistence of foetal and maternal DNA in the same sample (76).”
BackgroundChallenges in prenatal treatment with dexamethasone
(2018) · PubMed · doi:10.17458/per.vol16.2018.mcpa.dexamethasone · Cited by 30
Discordant fetal sex on NIPT and ultrasound
Smet, M.-E., Scott, F., & McLennan, A. (2020) · Prenatal Diagnosis · doi:10.1002/pd.5676 · Cited by 38
“impaired renal and pancreatic function, cognitive and behavioral problems.(102)”
BackgroundYoung, E. C., Bowns, B., Gerrish, A., Parks, M., Court, S., Clokie, S. J. H., Mashayamombe-Wolfgarten, C., Hewitt, J., Williams, D., Cole, T. R. P., et al. (2020) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2020.06.001 · Cited by 31
Clinical guidelines for the diagnosis and treatment of 21-hydroxylase deficiency (2021 revision)
Ishii, T., Kashimada, K., Amano, N., Takasawa, K., Nakamura‐Utsunomiya, A., Yatsuga, S., Mukai, T., Ida, S., Isobe, M., Fukushi, M., et al. (2022) · Clinical Pediatric Endocrinology · doi:10.1297/cpe.2022-0009 · Cited by 37
Coyne, L., & Stockdale, C. K. (2017) · Cambridge University Press eBooks · doi:10.1017/9781316662571.036 · Cited by 29
Koumbaris, G., Achilleos, A., Nicolaou, M., Loizides, C., Tsangaras, K., Kypri, E., Mina, P., Sismani, C., Velissariou, V., Christopoulou, G., et al. (2019) · Molecular Cytogenetics · doi:10.1186/s13039-019-0459-8 · Cited by 30
Zhong, L. P. W., & Chiu, R. W. K. (2022) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-110821-113411 · Cited by 30
Self-citationNoninvasive Approaches to Prenatal Diagnosis: Historical Perspective and Future Directions
Hui, L. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-8889-1_3 · Cited by 34
Russian clinical practice guidelines «congenital adrenal hyperplasia»
Mokrysheva, N. G., Mel'nichenko, G. A., Adamyan, L. V., Troshina, E. A., Молашенко, Н. В., Игоревна, С. А., Uvarova, E. V., Esayan, E. R. M., Andreeva, E. N., Ужегова, Ж. А., et al. (2021) · Obesity and metabolism · doi:10.14341/omet12787 · Cited by 30
Peng, X., Li, H., Wu, F., & Wang, J. (2020) · Briefings in Bioinformatics · doi:10.1093/bib/bbaa060 · Cited by 30
Congenital Adrenal Hyperplasias Presenting in the Newborn and Young Infant
Balsamo, A., Baronio, F., Ortolano, R., Menabò, S., Baldazzi, L., Natale, V. D., Vissani, S., & Cassio, A. (2020) · Frontiers in Pediatrics · doi:10.3389/fped.2020.593315 · Cited by 30
“A non-invasive method using cell-free fetal DNA in maternal plasma (NIPD at 5 weeks of gestation) could allow selective treatment in affected females only (54) but is not routinely performed due to its complexity and associated cost.”
MethodLajić, S., Karlsson, L., & Nordenström, A. (2018) · Hormone Research in Paediatrics · doi:10.1159/000485100 · Cited by 32
Prenatal Diagnosis of Congenital Adrenal Hyperplasia
Yau, M., Khattab, A., & New, M. I. (2016) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2016.01.001 · Cited by 26
“The use of targeted massive parallel sequencing of cell-free fetal DNA in maternal plasma for the noninvasive prenatal diagnosis of CAH owing to 21OHD was reported in May 2014.(102) In this study, 14 expectant families, each with a child affected with”
Self-citationLi, H., Zhu, X., Yang, Y., Wang, W., Mao, A., Li, J., Bao, S., & Li, J. (2023) · Clinica Chimica Acta · doi:10.1016/j.cca.2023.117419 · Cited by 23
Liquid biopsy: state of reproductive medicine and beyond
Schobers, G., Koeck, R. M., Pellaers, D., Stevens, S. J. C., Macville, M. V. E., Paulussen, A. D. C., Coonen, E., van den Wijngaard, A., de Die-Smulders, C. E. M., de Wert, G. M. W. R., et al. (2021) · Human Reproduction · doi:10.1093/humrep/deab206 · Cited by 26
“NIPT-M Prenatal diagnosis of congenital adrenal hyperplasia (New et al., 2014)”
BackgroundPrenatal dexamethasone treatment for classic 21-hydroxylase deficiency in Europe
Nowotny, H., Neumann, U., Tardy-Guidollet, V., Ahmed, S. F., Baronio, F., Battelino, T., Bertherat, J. Y., Blankenstein, O., Bonomi, M., Bouvattier, C. M., et al. (2022) · European Journal of Endocrinology · doi:10.1530/eje-21-0554 · Cited by 27
Xiong, W., Wang, D., Gao, Y., Gao, Y. M., Wang, H., Guan, J., Lan, L., Yan, J., Zong, L., Yuan, Y., et al. (2015) · Science China Life Sciences · doi:10.1007/s11427-015-4936-y · Cited by 23
Chang, M. Y., Kim, A. R., Kim, M. Y., Kim, S., Yoon, J., Han, J. J., Ahn, S., Kang, C. P., & Choi, B. Y. (2016) · Scientific Reports · doi:10.1038/srep37153 · Cited by 23
Self-citationFertility in patients with nonclassical congenital adrenal hyperplasia
New, M. I., Ghizzoni, L., Meyer‐Bahlburg, H. F. L., Khattab, A., Reichman, D. E., & Rosenwaks, Z. (2019) · Fertility and Sterility · doi:10.1016/j.fertnstert.2018.11.023 · Cited by 27
Self-citationLuo, Y., Jia, B., Yan, K., Liu, S., Song, X., Chen, M., Jin, F., Du, Y., Wang, J., Hong, Y., et al. (2019) · Molecular Genetics & Genomic Medicine · doi:10.1002/mgg3.597 · Cited by 23
“Subsequently, between 2015 and 2017, a number of reports have demonstrated that fetal single‐gene disorders such as congenital adrenal hyperplasia, Duchenne muscular dystrophy, and type I Gaucher disease could also be identified via the noninvasive NGS approach (New et al., 2014; Xu et al., 2015; Zeevi et al., 2015).”
BackgroundPediatric Disorders of Sex Development
Achermann, J. C., & Hughes, I. A. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-29738-7.00023-x · Cited by 29
Transition of adolescents and young adults with endocrine diseases to adult health care
Kapellen, T. M., & Kieß, W. (2015) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2015.03.005 · Cited by 22
Thung, D. T., Beulen, L., Hehir-Kwa, J., & Faas, B. H. (2015) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.2015.973857 · Cited by 20
“Recently, however, targeted MPS has been used on both the parents and ccffDNA for the diagnosis of recessive disorders such as congenital deafness [107] and congenital adrenal hyperplasia [108].”
BackgroundWang, W., Yuan, Y., Zheng, H., Wang, Y., Zeng, D. L., Yang, Y., Yi, X., Xia, Y., & Zhu, C. (2017) · Genetic Testing and Molecular Biomarkers · doi:10.1089/gtmb.2016.0411 · Cited by 21
“Later on, the noninvasive detection of maternal inherited mutations has been realized by the combinational application of massively parallel sequencing technology and the haplotype-assisted linkage analysis (Lo et al., 2010; Lam et al., 2012; Meng et al., 2014; New et al., 2014; You et al., 2014).”
MethodFrom late fatherhood to prenatal screening of monogenic disorders: evidence and ethical concerns
Zhytnik, L., Peters, M., Tilk, K., Simm, K., Tõnisson, N., Reimand, T., Maasalu, K., Acharya, G., Krjutškov, K., & Salumets, A. (2021) · Human Reproduction Update · doi:10.1093/humupd/dmab023 · Cited by 22
A Forward Look At Noninvasive Prenatal Testing
Liu, L., Li, K., Fu, X., Chung, C., & Zhang, K. (2016) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2016.09.008 · Cited by 19
Metadata
- Authors
- New, M. I., Tong, Y. K., Yuen, T., Jiang, P., Pina, C., Chan, K. C. A., Khattab, A., Liao, G. J. W., Yau, M., Kim, S.-M., Chiu, R. W. K., Sun, L., Zaidi, M., & Lo, Y. M.
- Affiliations
- Mount Sinai Hospital (US)
- Chinese University of Hong Kong (HK)
- Corresponding author
- New, Maria I.
- Lo, Y. M.
- ORCID
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2014-06-01
- Volume
- 99
- Issue
- 6
- Pages
- E1022-E1030
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- PMC
- PMC4037720
- OpenAlex
- W2097351942
- Cited by
- 319
- References
- 28
- Citations by year
- 2026: 4 · 2025: 13 · 2024: 18 · 2023: 23 · 2022: 15 · 2021: 18 · 2020: 15 · 2019: 23 · 2018: 32 · 2017: 88 · 2016: 25 · 2015: 36 · 2014: 8
- FWCI
- 49.18
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute on Aging (R01AG040132, AG-23176, AG40132, R01AG023176)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK80459, R01DK080459)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (AR65932, R01AR065932)
- Topics
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Prenatal Screening and Diagnostics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Sexual Differentiation and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
- Keywords
- congenital adrenal hyperplasia, noninvasive prenatal diagnosis, cell-free fetal DNA, maternal plasma, CYP21A2, 21-hydroxylase, haplotype analysis, targeted sequencing, autosomal recessive disorder
- MeSH terms
- Adrenal Hyperplasia, Congenital, Base Sequence, Cell-Free System, DNA, DNA Mutational Analysis, Female, Fetus, Humans, Pedigree, Pregnancy, Prenatal Diagnosis, Steroid 21-Hydroxylase, Polymorphism, Single Nucleotide
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.